NeuroSense Therapeutics is a clinical stage drug development company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.

Biotechnology

NeuroSense Therapeutics

NeuroSense Therapeutics' headquarters in Herzliya, Israel

Alon Ben-Noon

Keren Pushett

Diana Shtossel

Hagit Binder

Or Eisenberg

Ferenc Tracik

Oron Yacoby-Zeevi

Jinsy Andrews

Merit Cudkowicz

Orla Hardiman

Christine Pellizzari

Mark Leuchtenberger

Cary Claiborne

Yossi Gilgun-Sherki

Jeremy Shefner

Revital Mandil-Levin

Jeffrey Rosenfeld

The Scientific Roles team at NeuroSense Therapeutics is dedicated to advancing research and development for innovative therapies targeting ALS and other neurodegenerative diseases. Comprising experts in scientific strategy and project management, the team collaborates on the design and execution of clinical studies, ensures regulatory compliance, and provides critical insights to drive the therapeutic pipeline forward. Their collective expertise guides the company’s scientific vision and fosters partnerships to enhance therapeutic outcomes for patients.

Scientific Roles

The Board Governance team at NeuroSense Therapeutics is responsible for overseeing the company's strategic direction, ensuring compliance with regulatory standards, and providing expert guidance on clinical and operational matters. Comprised of experienced board members and advisors, the team fosters collaboration and accountability, facilitating informed decision-making to drive the development of innovative treatments for ALS and other neurodegenerative diseases.

Board Governance

The Leadership Team at NeuroSense Therapeutics drives the strategic vision and operational effectiveness of the company as it advances innovative therapies for ALS and other neurodegenerative diseases. Comprising experts in research, clinical operations, finance, and regulatory affairs, this team collaborates to ensure efficient drug development, secure funding, and navigate complex regulatory landscapes while maintaining a strong focus on patient outcomes and scientific integrity.

Leadership Team

The Business Operations team at NeuroSense Therapeutics is responsible for streamlining organizational processes, optimizing resource allocation, and ensuring effective cross-departmental collaboration. This team plays a crucial role in supporting the strategic growth of the company by overseeing human resources, financial planning, and operational efficiency, all with the goal of advancing innovative treatments for ALS and other neurodegenerative diseases.

Business Operations

The Regulatory Affairs team at NeuroSense Therapeutics is responsible for navigating the complex landscape of regulatory requirements to ensure the successful development and approval of innovative treatments for neurodegenerative diseases, including ALS. This team collaborates closely with clinical and manufacturing teams, leading the submission of regulatory documents and managing communication with health authorities to facilitate timely progress through clinical trials and product approvals. Their expertise is crucial in aligning the company’s drug development strategy with regulatory standards, ensuring compliance, and ultimately advancing patient access to new therapies.

NeuroSense Therapeutics

Org chart

Board & advisors

Teams

Scientific Roles

Board Governance

Leadership Team

Business Operations

Regulatory Affairs

Offices

NeuroSense Therapeutics

Org chart

Board & advisors

Teams

Scientific Roles

Board Governance

Leadership Team

Business Operations

Regulatory Affairs

Offices

Related companies